BVAXF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Apr 23 closing price
Capitalization
8.43M
GSGTF
Price
$0.24
Change
-$0.08 (-25.00%)
Updated
Dec 31 closing price
Capitalization
31.39M
Ad is loading...

BVAXF vs GSGTF

Header iconBVAXF vs GSGTF Comparison
Open Charts BVAXF vs GSGTFBanner chart's image
BioVaxys Technology
Price$0.03
Change-$0.00 (-0.00%)
Volume$720.6K
Capitalization8.43M
Gensight Biologics SA
Price$0.24
Change-$0.08 (-25.00%)
Volume$4.01K
Capitalization31.39M
BVAXF vs GSGTF Comparison Chart
Loading...
View a ticker or compare two or three
VS
BVAXF vs. GSGTF commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVAXF is a Hold and GSGTF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (BVAXF: $0.03 vs. GSGTF: $0.24)
Brand notoriety: BVAXF and GSGTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVAXF: 219% vs. GSGTF: 100%
Market capitalization -- BVAXF: $8.43M vs. GSGTF: $31.39M
BVAXF [@Biotechnology] is valued at $8.43M. GSGTF’s [@Biotechnology] market capitalization is $31.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVAXF’s FA Score shows that 0 FA rating(s) are green whileGSGTF’s FA Score has 0 green FA rating(s).

  • BVAXF’s FA Score: 0 green, 5 red.
  • GSGTF’s FA Score: 0 green, 5 red.
According to our system of comparison, BVAXF is a better buy in the long-term than GSGTF.

Price Growth

BVAXF (@Biotechnology) experienced а -26.29% price change this week, while GSGTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

BVAXF is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
GSGTF($31.4M) has a higher market cap than BVAXF($8.43M). GSGTF YTD gains are higher at: 0.000 vs. BVAXF (-32.388).
BVAXFGSGTFBVAXF / GSGTF
Capitalization8.43M31.4M27%
EBITDA-4.13MN/A-
Gain YTD-32.3880.000-
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash157KN/A-
Total Debt67.7KN/A-
FUNDAMENTALS RATINGS
BVAXF vs GSGTF: Fundamental Ratings
BVAXF
GSGTF
OUTLOOK RATING
1..100
5643
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
99100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
9075
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BVAXF's Valuation (45) in the null industry is somewhat better than the same rating for GSGTF (86). This means that BVAXF’s stock grew somewhat faster than GSGTF’s over the last 12 months.

BVAXF's Profit vs Risk Rating (99) in the null industry is in the same range as GSGTF (100). This means that BVAXF’s stock grew similarly to GSGTF’s over the last 12 months.

GSGTF's SMR Rating (97) in the null industry is in the same range as BVAXF (99). This means that GSGTF’s stock grew similarly to BVAXF’s over the last 12 months.

GSGTF's Price Growth Rating (75) in the null industry is in the same range as BVAXF (90). This means that GSGTF’s stock grew similarly to BVAXF’s over the last 12 months.

GSGTF's P/E Growth Rating (100) in the null industry is in the same range as BVAXF (100). This means that GSGTF’s stock grew similarly to BVAXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GOOY11.690.23
+2.01%
YieldMax GOOGL Option Income Stgy ETF
DFUS57.930.95
+1.67%
Dimensional US Equity Market ETF
BJAN45.150.52
+1.17%
Innovator US Equity Buff ETF™ Jan
EMO44.570.32
+0.72%
ClearBridge Energy Midstream Opportunity Fund
FTDS48.410.26
+0.53%
First Trust Dividend Strength ETF

BVAXF and

Correlation & Price change

A.I.dvisor tells us that BVAXF and GSGTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVAXF and GSGTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVAXF
1D Price
Change %
BVAXF100%
-4.98%
GSGTF - BVAXF
29%
Poorly correlated
N/A
THTX - BVAXF
24%
Poorly correlated
-1.47%
EDSA - BVAXF
21%
Poorly correlated
+1.30%
CSBR - BVAXF
21%
Poorly correlated
+1.78%
SQZB - BVAXF
14%
Poorly correlated
N/A
More

GSGTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSGTF has been loosely correlated with HRTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GSGTF jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSGTF
1D Price
Change %
GSGTF100%
N/A
HRTX - GSGTF
45%
Loosely correlated
+2.33%
RPTX - GSGTF
34%
Loosely correlated
-6.57%
GOSS - GSGTF
30%
Poorly correlated
+7.51%
BVAXF - GSGTF
29%
Poorly correlated
-4.98%
SPRC - GSGTF
29%
Poorly correlated
+4.52%
More